|
1
|
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel.
|
J Allergy Clin Immunol
|
2010
|
5.55
|
|
2
|
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report.
|
J Allergy Clin Immunol
|
2010
|
2.98
|
|
3
|
Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper.
|
Ann Allergy Asthma Immunol
|
2007
|
1.77
|
|
4
|
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease.
|
Ann Allergy Asthma Immunol
|
2005
|
1.69
|
|
5
|
Food allergy: a practice parameter update-2014.
|
J Allergy Clin Immunol
|
2014
|
1.60
|
|
6
|
Excess dampness and mold growth in homes: an evidence-based review of the aeroirritant effect and its potential causes.
|
Allergy Asthma Proc
|
2007
|
1.51
|
|
7
|
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-sponsored expert panel report.
|
Nutr Res
|
2011
|
1.14
|
|
8
|
The natural history and clinical characteristics of aspirin-exacerbated respiratory disease.
|
Ann Allergy Asthma Immunol
|
2002
|
1.14
|
|
9
|
Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease.
|
J Allergy Clin Immunol
|
2003
|
1.12
|
|
10
|
The safety of celecoxib in patients with aspirin-sensitive asthma.
|
Arthritis Rheum
|
2002
|
1.09
|
|
11
|
Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease.
|
J Allergy Clin Immunol
|
2006
|
1.00
|
|
12
|
The united allergic airway: connections between allergic rhinitis, asthma, and chronic sinusitis.
|
Am J Rhinol Allergy
|
2012
|
0.98
|
|
13
|
Aspirin sensitivity: implications for patients with coronary artery disease.
|
JAMA
|
2004
|
0.97
|
|
14
|
Effect of leukotriene modifier drugs on the safety of oral aspirin challenges.
|
Ann Allergy Asthma Immunol
|
2006
|
0.96
|
|
15
|
Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis.
|
Ann Allergy Asthma Immunol
|
2008
|
0.95
|
|
16
|
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report.
|
Nutrition
|
2011
|
0.92
|
|
17
|
Selection of patients for aspirin desensitization treatment.
|
J Allergy Clin Immunol
|
2006
|
0.90
|
|
18
|
Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease.
|
Ann Allergy Asthma Immunol
|
2003
|
0.87
|
|
19
|
Sensitivity to nonsteroidal anti-inflammatory drugs.
|
Ann Allergy Asthma Immunol
|
2002
|
0.86
|
|
20
|
Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease.
|
Ann Allergy Asthma Immunol
|
2010
|
0.86
|
|
21
|
Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease.
|
J Allergy Clin Immunol
|
2008
|
0.85
|
|
22
|
Guidelines for the diagnosis and management of food allergy in the United States: summary of the NIAID-Sponsored Expert Panel report.
|
J Am Acad Dermatol
|
2011
|
0.85
|
|
23
|
Aspirin-exacerbated respiratory disease: burden of disease.
|
Allergy Asthma Proc
|
2012
|
0.85
|
|
24
|
Clopidogrel desensitization after drug-eluting stent placement.
|
J Am Coll Cardiol
|
2007
|
0.83
|
|
25
|
The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges.
|
J Allergy Clin Immunol
|
2007
|
0.83
|
|
26
|
Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
|
Ann Allergy Asthma Immunol
|
2004
|
0.78
|
|
27
|
Does it make sense to "desens"? Aspirin desensitization in the treatment of chronic rhinosinusitis.
|
Curr Allergy Asthma Rep
|
2006
|
0.78
|
|
28
|
Cardiovascular prophylaxis and aspirin "allergy".
|
Immunol Allergy Clin North Am
|
2012
|
0.78
|
|
29
|
The Difficult-to-Control Asthmatic: A Systematic Approach.
|
Allergy Asthma Clin Immunol
|
2006
|
0.77
|
|
30
|
Supraesophageal reflux disease: a review of the literature.
|
Allergy Asthma Proc
|
2014
|
0.77
|
|
31
|
Making the call: the diagnosis of acute community-acquired bacterial sinusitis.
|
Am J Rhinol
|
2006
|
0.77
|
|
32
|
Failure of tacrolimus to prevent aspirin-induced respiratory reactions in patients with aspirin-exacerbated respiratory disease.
|
J Allergy Clin Immunol
|
2005
|
0.76
|
|
33
|
Aspirin as a cause of pancreatitis in patients with aspirin-exacerbated respiratory disease.
|
J Allergy Clin Immunol
|
2012
|
0.76
|
|
34
|
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors.
|
Ann Allergy Asthma Immunol
|
2005
|
0.75
|
|
35
|
Evidence-based protocols for oral NSAID challenges.
|
J Pediatr
|
2006
|
0.75
|
|
36
|
Aspirin-exacerbated respiratory disease: is it in our DNA?
|
Ann Allergy Asthma Immunol
|
2011
|
0.75
|
|
37
|
Macrolide antibiotics as anti-inflammatory agents.
|
Curr Allergy Asthma Rep
|
2005
|
0.75
|
|
38
|
Sinusitis and chronic progressive exercise-induced cough and dyspnea.
|
Allergy Asthma Proc
|
2009
|
0.75
|
|
39
|
Assessment of sensitization risk of a laundry pre-spotter containing protease.
|
Cutan Ocul Toxicol
|
2011
|
0.75
|
|
40
|
Approach to patients with aspirin hypersensitivity and acute cardiovascular emergencies.
|
Allergy Asthma Proc
|
2013
|
0.75
|